Organoids Market Size, Trends & Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Organoids Market Size Analysis

Global Organoids Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Neural Organoids
    1. By Value
  3. Hepatic Organoids
    1. By Value
  4. Intestinal Organoids
    1. By Value
  5. Other Organoids
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. General Submerged Method for Organoid Culture
    1. By Value
  3. Crypt Organoid Culture Techniques
    1. By Value
  4. Air Liquid Interface (ALI) Method for Organoid Culture
    1. By Value
  5. Clonal Organoids from Lgr5+ Cells
    1. By Value
  6. Brain and Retina Organoid Formation Protocol
    1. By Value
  7. Others
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Primary Tissues
    1. By Value
  3. Stem Cells
    1. By Value
    2. Induced Pluripotent Stem Cells (iPSCs)
      1. Induced Pluripotent Stem Cells (iPSCs) By Value
    3. Others
      1. Others By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Developmental Biology
    1. By Value
  3. Personalized Medicine
    1. By Value
  4. Regenerative Medicine
    1. By Value
  5. Disease Pathology Studies
    1. By Value
  6. Drug Toxicity & Efficacy Testing
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Hospitals and Diagnostic Labs
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Neural Organoids
    1. By Value
  3. Hepatic Organoids
    1. By Value
  4. Intestinal Organoids
    1. By Value
  5. Other Organoids
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. General Submerged Method for Organoid Culture
    1. By Value
  3. Crypt Organoid Culture Techniques
    1. By Value
  4. Air Liquid Interface (ALI) Method for Organoid Culture
    1. By Value
  5. Clonal Organoids from Lgr5+ Cells
    1. By Value
  6. Brain and Retina Organoid Formation Protocol
    1. By Value
  7. Others
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Primary Tissues
    1. By Value
  3. Stem Cells
    1. By Value
    2. Induced Pluripotent Stem Cells (iPSCs)
      1. Induced Pluripotent Stem Cells (iPSCs) By Value
    3. Others
      1. Others By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Developmental Biology
    1. By Value
  3. Personalized Medicine
    1. By Value
  4. Regenerative Medicine
    1. By Value
  5. Disease Pathology Studies
    1. By Value
  6. Drug Toxicity & Efficacy Testing
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Hospitals and Diagnostic Labs
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Neural Organoids
    1. By Value
  3. Hepatic Organoids
    1. By Value
  4. Intestinal Organoids
    1. By Value
  5. Other Organoids
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. General Submerged Method for Organoid Culture
    1. By Value
  3. Crypt Organoid Culture Techniques
    1. By Value
  4. Air Liquid Interface (ALI) Method for Organoid Culture
    1. By Value
  5. Clonal Organoids from Lgr5+ Cells
    1. By Value
  6. Brain and Retina Organoid Formation Protocol
    1. By Value
  7. Others
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Primary Tissues
    1. By Value
  3. Stem Cells
    1. By Value
    2. Induced Pluripotent Stem Cells (iPSCs)
      1. Induced Pluripotent Stem Cells (iPSCs) By Value
    3. Others
      1. Others By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Developmental Biology
    1. By Value
  3. Personalized Medicine
    1. By Value
  4. Regenerative Medicine
    1. By Value
  5. Disease Pathology Studies
    1. By Value
  6. Drug Toxicity & Efficacy Testing
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Hospitals and Diagnostic Labs
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Neural Organoids
    1. By Value
  3. Hepatic Organoids
    1. By Value
  4. Intestinal Organoids
    1. By Value
  5. Other Organoids
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. General Submerged Method for Organoid Culture
    1. By Value
  3. Crypt Organoid Culture Techniques
    1. By Value
  4. Air Liquid Interface (ALI) Method for Organoid Culture
    1. By Value
  5. Clonal Organoids from Lgr5+ Cells
    1. By Value
  6. Brain and Retina Organoid Formation Protocol
    1. By Value
  7. Others
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Primary Tissues
    1. By Value
  3. Stem Cells
    1. By Value
    2. Induced Pluripotent Stem Cells (iPSCs)
      1. Induced Pluripotent Stem Cells (iPSCs) By Value
    3. Others
      1. Others By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Developmental Biology
    1. By Value
  3. Personalized Medicine
    1. By Value
  4. Regenerative Medicine
    1. By Value
  5. Disease Pathology Studies
    1. By Value
  6. Drug Toxicity & Efficacy Testing
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Hospitals and Diagnostic Labs
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Neural Organoids
  1. By Value
3. Hepatic Organoids
  1. By Value
4. Intestinal Organoids
  1. By Value
5. Other Organoids
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. General Submerged Method for Organoid Culture
  1. By Value
3. Crypt Organoid Culture Techniques
  1. By Value
4. Air Liquid Interface (ALI) Method for Organoid Culture
  1. By Value
5. Clonal Organoids from Lgr5+ Cells
  1. By Value
6. Brain and Retina Organoid Formation Protocol
  1. By Value
7. Others
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Primary Tissues
  1. By Value
3. Stem Cells
  1. By Value
  2. Induced Pluripotent Stem Cells (iPSCs)
    1. Induced Pluripotent Stem Cells (iPSCs) By Value
  3. Others
    1. Others By Value
By Applications
1. Introduction
  1. Applications By Value
2. Developmental Biology
  1. By Value
3. Personalized Medicine
  1. By Value
4. Regenerative Medicine
  1. By Value
5. Disease Pathology Studies
  1. By Value
6. Drug Toxicity & Efficacy Testing
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotechnology Companies
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Hospitals and Diagnostic Labs
  1. By Value
5. Others
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Neural Organoids
    1. By Value
  3. Hepatic Organoids
    1. By Value
  4. Intestinal Organoids
    1. By Value
  5. Other Organoids
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. General Submerged Method for Organoid Culture
    1. By Value
  3. Crypt Organoid Culture Techniques
    1. By Value
  4. Air Liquid Interface (ALI) Method for Organoid Culture
    1. By Value
  5. Clonal Organoids from Lgr5+ Cells
    1. By Value
  6. Brain and Retina Organoid Formation Protocol
    1. By Value
  7. Others
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Primary Tissues
    1. By Value
  3. Stem Cells
    1. By Value
    2. Induced Pluripotent Stem Cells (iPSCs)
      1. Induced Pluripotent Stem Cells (iPSCs) By Value
    3. Others
      1. Others By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Developmental Biology
    1. By Value
  3. Personalized Medicine
    1. By Value
  4. Regenerative Medicine
    1. By Value
  5. Disease Pathology Studies
    1. By Value
  6. Drug Toxicity & Efficacy Testing
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotechnology Companies
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Hospitals and Diagnostic Labs
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Organoids Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Mimetas
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
DefiniGen
PreComb
Axol Biosciences
Danaher Corporation (Cellesce & Molecular Devices)
Newcells
Crown Biosciences
Ncardia
Cell Microsystems
Corning Incorporated
AMS Biotechnology (Europe) Limited
Greiner Bio-One
Hubrecht Organoid Technology (HUB)
Organovo, Inc.
InSphero

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment